The New York Times Cuts Through the Hype on GMOs

They’re likely safe to eat, but they sure haven’t lived up to their high-yield, low-pesticide promise.

Eighty percent of US corn, by far our biggest crop, is genetically modified. What has that gained us? <a href="http://www.istockphoto.com/photo/farm-machines-harvesting-corn-for-feed-or-ethanol-gm604352678-103773711?st=_p_field%20of%20corn">James Brey</a>/iStock

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


Genetically modified seeds emerged in the mid-1990s and have since conquered million of acres of US farmland. Today, upward of 80 percent of corn, soybean, and cotton acreage is planted with crops engineered to withstand herbicides or insects, as have large portions of our sugar beet and alfalfa crops. Beyond the massive marketing triumph and financial success of companies like Monsanto and Syngenta—which sell both the seeds and the related herbicides—what has the industry achieved in terms of public benefits?

Have they helped farmers churn out more food per acre and reduce pesticides, as the industry has long claimed? Or, as some of their more extreme critics suggest, are they subtly poisoning the food supply?

Europe essentially rejected GMOs—and paid no price for it.

In Sunday’s New York Times, investigative journalist Danny Hakim has an elegant, in-depth piece digging beneath considerable industry hype to examine that question. His conclusion: While “fears that they are unsafe to eat” are  “largely unsubstantiated,” “genetic modification in the United States and Canada has not accelerated increases in crop yields or led to an overall reduction in the use of chemical pesticides.”

To reach that conclusion, Hakim compared US yields of crops like corn and sugar beets with the same crops grown in Europe (charts here), where GMOs aren’t widely used. He also compared pesticide-use rates. The result: “The United States and Canada have gained no discernible advantage in yields—food per acre—when measured against Western Europe, a region with comparably modernized agricultural producers like France and Germany.” The result, he notes, is consistent with a recent National Academy of Sciences report that found that “there was little evidence that the introduction of genetically modified crops in the United States had led to yield gains beyond those seen in conventional crops.”

Shorter: Europe essentially rejected GMOs and paid no price for it.

For pesticides, the performance has been mixed, but not exactly an affirmation of GMO crops’ 20-year run.

One measure, contained in data from the United States Geological Survey, shows the stark difference in the use of pesticides. Since genetically modified crops were introduced in the United States two decades ago for crops like corn, cotton and soybeans, the use of toxins that kill insects and fungi has fallen by a third, but the spraying of herbicides, which are used in much higher volumes, has risen by 21 percent.By contrast, in France, use of insecticides and fungicides has fallen by a far greater percentage—65 percent—and herbicide use has decreased as well, by 36 percent.

The article has predictably generated a storm of criticism from industry enthusiasts. Hakim answered some of them in a tweetstorm Sunday morning (start here). I’ll have more to say about it later this week. In the meantime, as someone who has been teasing out this story for a decade, it’s refreshing to see the topic covered with such precision and clarity in the paper of record.

WE'LL BE BLUNT.

We have a considerable $390,000 gap in our online fundraising budget that we have to close by June 30. There is no wiggle room, we've already cut everything we can, and we urgently need more readers to pitch in—especially from this specific blurb you're reading right now.

We'll also be quite transparent and level-headed with you about this.

In "News Never Pays," our fearless CEO, Monika Bauerlein, connects the dots on several concerning media trends that, taken together, expose the fallacy behind the tragic state of journalism right now: That the marketplace will take care of providing the free and independent press citizens in a democracy need, and the Next New Thing to invest millions in will fix the problem. Bottom line: Journalism that serves the people needs the support of the people. That's the Next New Thing.

And it's what MoJo and our community of readers have been doing for 47 years now.

But staying afloat is harder than ever.

In "This Is Not a Crisis. It's The New Normal," we explain, as matter-of-factly as we can, what exactly our finances look like, why this moment is particularly urgent, and how we can best communicate that without screaming OMG PLEASE HELP over and over. We also touch on our history and how our nonprofit model makes Mother Jones different than most of the news out there: Letting us go deep, focus on underreported beats, and bring unique perspectives to the day's news.

You're here for reporting like that, not fundraising, but one cannot exist without the other, and it's vitally important that we hit our intimidating $390,000 number in online donations by June 30.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. It's going to be a nail-biter, and we really need to see donations from this specific ask coming in strong if we're going to get there.

payment methods

WE'LL BE BLUNT.

We have a considerable $390,000 gap in our online fundraising budget that we have to close by June 30. There is no wiggle room, we've already cut everything we can, and we urgently need more readers to pitch in—especially from this specific blurb you're reading right now.

We'll also be quite transparent and level-headed with you about this.

In "News Never Pays," our fearless CEO, Monika Bauerlein, connects the dots on several concerning media trends that, taken together, expose the fallacy behind the tragic state of journalism right now: That the marketplace will take care of providing the free and independent press citizens in a democracy need, and the Next New Thing to invest millions in will fix the problem. Bottom line: Journalism that serves the people needs the support of the people. That's the Next New Thing.

And it's what MoJo and our community of readers have been doing for 47 years now.

But staying afloat is harder than ever.

In "This Is Not a Crisis. It's The New Normal," we explain, as matter-of-factly as we can, what exactly our finances look like, why this moment is particularly urgent, and how we can best communicate that without screaming OMG PLEASE HELP over and over. We also touch on our history and how our nonprofit model makes Mother Jones different than most of the news out there: Letting us go deep, focus on underreported beats, and bring unique perspectives to the day's news.

You're here for reporting like that, not fundraising, but one cannot exist without the other, and it's vitally important that we hit our intimidating $390,000 number in online donations by June 30.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. It's going to be a nail-biter, and we really need to see donations from this specific ask coming in strong if we're going to get there.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate